Aclarion, Inc. financial data

Symbol
ACON, ACONW on Nasdaq
Industry
Services-Medical Laboratories
Location
8181 Arista Place, Ste 100, Broomfield, CO
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Nocimed, Inc. (to 10/26/2021)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 73.5 % -44.3%
Return On Equity -911 % -174%
Return On Assets -218 % -13.6%
Operating Margin -8.71K % -40.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.61M shares +5%
Common Stock, Shares, Outstanding 8.21M shares +0.12%
Entity Public Float 4.67M USD -6.91%
Common Stock, Value, Issued 82 USD 0%
Weighted Average Number of Shares Outstanding, Basic 8.22M shares +1486%
Weighted Average Number of Shares Outstanding, Diluted 8.22M shares +1486%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 53.9K USD -35.2%
Cost of Revenue 81.7K USD +15%
Research and Development Expense 860K USD -10.8%
Selling and Marketing Expense 778K USD +12.9%
General and Administrative Expense 3.03M USD -13.9%
Operating Income (Loss) -4.7M USD +8.98%
Nonoperating Income (Expense) -1.2M USD -1823%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.9M USD +15.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -5.9M USD -12.9%
Earnings Per Share, Basic -4.19 USD/shares +81.8%
Earnings Per Share, Diluted -4.19 USD/shares +81.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.17M USD
Accounts Receivable, after Allowance for Credit Loss, Current 19.7K USD +90.2%
Assets, Current 1.85M USD +132%
Property, Plant and Equipment, Net 1.19K USD -49.2%
Intangible Assets, Net (Excluding Goodwill) 1.24M USD +2.64%
Assets 3.09M USD +54.1%
Accounts Payable, Current 179K USD -70.5%
Accrued Liabilities, Current 12.1K USD
Liabilities, Current 1.45M USD -27.5%
Liabilities 1.45M USD
Retained Earnings (Accumulated Deficit) -47.9M USD -14%
Stockholders' Equity Attributable to Parent 1.64M USD +15964%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 0 USD
Liabilities and Equity 3.09M USD +54.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.24M USD -121%
Net Cash Provided by (Used in) Financing Activities 3.41M USD
Net Cash Provided by (Used in) Investing Activities -63.7K USD -443%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.21M shares +0.12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.18M USD +92.5%
Deferred Tax Assets, Valuation Allowance 9.71M USD
Deferred Tax Assets, Gross 9.71M USD
Property, Plant and Equipment, Gross 55.2K USD -24.8%
Deferred Tax Assets, Operating Loss Carryforwards 9.24M USD
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 49.6M USD +17.9%
Amortization of Intangible Assets 173K USD +14%
Depreciation, Depletion and Amortization 45.1K USD +14.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 702K USD +14725%
Interest Expense 943K USD -30%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%